DeltaV Workflow Management delivers scalable
recipe authoring and execution technologies for life sciences
companies
ST.
LOUIS, April 16, 2024 /PRNewswire/ -- Global
automation technology and software leader Emerson (NYSE: EMR)
today introduced DeltaV™ Workflow Management, a next-generation
software designed for life sciences companies in early-stage
development. The new software continues Emerson's expansion of
capabilities of the evolving DeltaV automation platform to offer
more scalable options to suit the needs of smaller life sciences
innovators. For companies with limited IT infrastructure, DeltaV
Workflow Management provides a cloud-based, software-as-a-service
solution for simple recipe authoring, execution and electronic data
capture.
In high-growth life sciences companies, such as those making
advanced therapy medicinal products for hard-to-treat diseases and
personalized medicines, manufacturing facilities still heavily rely
on manual processes and record-keeping for bench-scale operations
and recipe authoring. Many do not have robust IT departments, nor
staff experienced in the complex coding necessary with traditional
manufacturing execution systems.
DeltaV Workflow Management removes this layer of complexity by
transitioning recipe workflow data from manual records to digital
"paper on glass," providing a simple and scalable solution that
helps accelerate the drug development process with no coding
experience required. The software also generates searchable digital
records that are easily organized and exported and data that can be
more easily analyzed and reported. In addition, this digital shift
minimizes the contamination risks associated with paper records in
sterile clean rooms.
"DeltaV Workflow Management enables innovation for both startups
and established labs that demand speed and simplicity in
early-stage drug development," said Nathan
Pettus, president of Emerson's process systems and solutions
business. "Recipes relying on standard, full-blown manufacturing
execution systems can take years of experience and months to create
and fully automate. With this new software, the timeline is reduced
to days, providing companies with a head start toward
commercialization and getting new therapeutic medicines into the
pipeline faster."
Within DeltaV Workflow Management, users employ simple
drag-and-drop elements to create steps for a recipe and automate
workflows that meet Good Manufacturing Practice standards. Within
those steps, they can add new parameters and e-signature
requirements for quality control and regulatory compliance, run
product recipes, authorize users for specific tasks and create
digital batch records.
DeltaV Workflow Management expands and complements the user
options for digital recipe development and execution already
provided by Emerson's DeltaV MES—the newest evolution of the
Syncade MES. Users now have additional flexibility to match digital
recipe solutions to their business needs, underscoring Emerson's
commitment to continuing enhancement of and investment in a
portfolio of manufacturing execution solutions for organizations at
any scale.
About Emerson
Emerson (NYSE: EMR) is a global technology and software company
providing innovative solutions for the world's essential
industries. Through its leading automation portfolio, including its
majority stake in AspenTech, Emerson helps hybrid, process and
discrete manufacturers optimize operations, protect personnel,
reduce emissions and achieve their sustainability goals. For more
information, visit Emerson.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/emersons-next-generation-software-streamlines-pharmaceutical-development-accelerates-speed-to-market-302115695.html
SOURCE Emerson